
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Catalent Pharma Solutions announced the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility. As Catalents first Asia-Pacific region facility, it has provided additional GMP space for secondary packaging, has doubled ambient storage, and quadrupled cold storage capacity.
Read the full release






